Literature DB >> 25156742

Differential regulation of proinflammatory cytokine expression by mitogen-activated protein kinases in macrophages in response to intestinal parasite infection.

Mei Xing Lim1, Chin Wen Png1, Crispina Yan Bing Tay1, Joshua Ding Wei Teo2, Huipeng Jiao1, Norbert Lehming2, Kevin Shyong Wei Tan3, Yongliang Zhang4.   

Abstract

Blastocystis is a common enteric protistan parasite that can cause acute, as well as chronic, infection and is associated with irritable bowel syndrome (IBS). However, the pathogenic status of Blastocystis infection remains unclear. In this study, we found that Blastocystis antigens induced abundant expression of proinflammatory cytokines, including interleukin 1β (IL-1β), IL-6, and tumor necrosis factor alpha (TNF-α), in mouse intestinal explants, in mouse colitis colon, and in macrophages. Further investigation utilizing RAW264.7 murine macrophages showed that Blastocystis treatment in RAW264.7 macrophages induced the activation of ERK, JNK, and p38, the three major groups of mammalian mitogen-activated protein (MAP) kinases that play essential roles in the expression of proinflammatory cytokines. ERK inhibition in macrophages significantly suppressed both mRNA and protein expression of IL-6 and TNF-α and mRNA expression of IL-1β. On the other hand, JNK inhibition resulted in reductions in both c-Jun and ERK activation and significant suppression of all three proinflammatory cytokines at both the mRNA and protein levels. Inhibition of p38 suppressed only IL-6 protein expression with no effect on the expression of IL-1β and TNF-α. Furthermore, we found that serine proteases produced by Blastocystis play an important role in the induction of ERK activation and proinflammatory cytokine expression by macrophages. Our study thus demonstrated for the first time that Blastocystis could induce the expression of various proinflammatory cytokines via the activation of MAP kinases and that infection with Blastocystis may contribute to the pathogenesis of inflammatory intestinal diseases through the activation of inflammatory pathways in host immune cells, such as macrophages.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25156742      PMCID: PMC4249314          DOI: 10.1128/IAI.02279-14

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  71 in total

1.  Predominance of Blastocystis sp. subtype 4 in rural communities, Nepal.

Authors:  I L Lee; T C Tan; P C Tan; D R Nanthiney; M K Biraj; K M Surendra; K G Suresh
Journal:  Parasitol Res       Date:  2011-11-11       Impact factor: 2.289

2.  A metronidazole-resistant isolate of Blastocystis spp. is susceptible to nitric oxide and downregulates intestinal epithelial inducible nitric oxide synthase by a novel parasite survival mechanism.

Authors:  Haris Mirza; Zhaona Wu; Fahad Kidwai; Kevin S W Tan
Journal:  Infect Immun       Date:  2011-09-19       Impact factor: 3.441

Review 3.  Regulatory mechanisms and functions of MAP kinase signaling pathways.

Authors:  Masamichi Imajo; Yoshiki Tsuchiya; Eisuke Nishida
Journal:  IUBMB Life       Date:  2006 May-Jun       Impact factor: 3.885

4.  Involvement of MAPK activation in chemokine or COX-2 productions by Toxoplasma gondii.

Authors:  Ji-Young Kim; Myoung-Hee Ahn; Hyun-Ouk Song; Jong-Hak Choi; Jae-Sook Ryu; Duk-Young Min; Myung-Hwan Cho
Journal:  Korean J Parasitol       Date:  2006-09       Impact factor: 1.341

5.  Requirement of mitogen-activated protein kinases and I kappa B phosphorylation for induction of proinflammatory cytokines synthesis by macrophages indicates functional similarity of receptors triggered by glycosylphosphatidylinositol anchors from parasitic protozoa and bacterial lipopolysaccharide.

Authors:  C Ropert; I C Almeida; M Closel; L R Travassos; M A Ferguson; P Cohen; R T Gazzinelli
Journal:  J Immunol       Date:  2001-03-01       Impact factor: 5.422

6.  Extensive genetic diversity in Blastocystis hominis.

Authors:  C G Clark
Journal:  Mol Biochem Parasitol       Date:  1997-07       Impact factor: 1.759

7.  Prevalence and clinical relevance of Blastocystis hominis in diverse patient cohorts.

Authors:  O Cirioni; A Giacometti; D Drenaggi; F Ancarani; G Scalise
Journal:  Eur J Epidemiol       Date:  1999-04       Impact factor: 8.082

Review 8.  Irritable bowel syndrome: a review on the role of intestinal protozoa and the importance of their detection and diagnosis.

Authors:  D Stark; S van Hal; D Marriott; J Ellis; J Harkness
Journal:  Int J Parasitol       Date:  2006-10-12       Impact factor: 3.981

9.  Increased faecal serine protease activity in diarrhoeic IBS patients: a colonic lumenal factor impairing colonic permeability and sensitivity.

Authors:  K Gecse; R Róka; L Ferrier; M Leveque; H Eutamene; C Cartier; A Ait-Belgnaoui; A Rosztóczy; F Izbéki; J Fioramonti; T Wittmann; L Bueno
Journal:  Gut       Date:  2008-01-14       Impact factor: 23.059

10.  Blastocystis: getting to grips with our guileful guest.

Authors:  Pauline D Scanlan; Christen R Stensvold
Journal:  Trends Parasitol       Date:  2013-09-27
View more
  33 in total

1.  Didox (3,4-dihydroxybenzohydroxamic acid) suppresses IL-33-induced cytokine production in primary mouse mast cells.

Authors:  Heather L Caslin; Jamie Josephine Avila McLeod; Andrew J Spence; Amina Abdul Qayum; Elizabeth Motunrayo Kolawole; Marcela T Taruselli; Anuya Paranjape; Howard L Elford; John J Ryan
Journal:  Cell Immunol       Date:  2017-07-11       Impact factor: 4.868

2.  Functional Impairment of Murine Dendritic Cell Subsets following Infection with Infective Larval Stage 3 of Brugia malayi.

Authors:  Aditi Sharma; Pankaj Sharma; Achchhe Lal Vishwakarma; Mrigank Srivastava
Journal:  Infect Immun       Date:  2016-12-29       Impact factor: 3.441

Review 3.  Mechanism and therapeutic strategies of depression after myocardial infarction.

Authors:  Ying Yang; Xuping Li; Sixuan Chen; Mingzhu Xiao; Zhongqiu Liu; Jingyan Li; Yuanyuan Cheng
Journal:  Psychopharmacology (Berl)       Date:  2021-02-16       Impact factor: 4.530

Review 4.  Phosphoinositide 3-kinase/Akt and its related signaling pathways in the regulation of tumor-associated macrophages polarization.

Authors:  Depeng Yang; Lijun Yang; Jialing Cai; Huaxin Li; Zheng Xing; Ying Hou
Journal:  Mol Cell Biochem       Date:  2022-05-19       Impact factor: 3.842

5.  Viability Screen of LOPAC1280 Reveals Phosphorylation Inhibitor Auranofin as a Potent Inhibitor of Blastocystis Subtype 1, 4, and 7 Isolates.

Authors:  John Anthony Yason; Kristine Anne Ru Ping Koh; Kevin Shyong Wei Tan
Journal:  Antimicrob Agents Chemother       Date:  2018-07-27       Impact factor: 5.191

6.  Ceftriaxone Administration Disrupts Intestinal Homeostasis, Mediating Noninflammatory Proliferation and Dissemination of Commensal Enterococci.

Authors:  Rajrupa Chakraborty; Vy Lam; Sushma Kommineni; Jeremiah Stromich; Michael Hayward; Christopher J Kristich; Nita H Salzman
Journal:  Infect Immun       Date:  2018-11-20       Impact factor: 3.441

Review 7.  Cellular metabolomics of pulmonary fibrosis, from amino acids to lipids.

Authors:  Willy Roque; Freddy Romero
Journal:  Am J Physiol Cell Physiol       Date:  2021-01-20       Impact factor: 4.249

8.  Redox-sensitive Nrf2 and MAPK signaling pathways contribute to trichloroethene-mediated autoimmune disease progression.

Authors:  Nivedita Banerjee; Hui Wang; Gangduo Wang; Paul J Boor; M Firoze Khan
Journal:  Toxicology       Date:  2021-04-27       Impact factor: 4.571

9.  Ex Vivo and In Vivo Mice Models to Study Blastocystis spp. Adhesion, Colonization and Pathology: Closer to Proving Koch's Postulates.

Authors:  Sitara S R Ajjampur; Chin Wen Png; Wan Ni Chia; Yongliang Zhang; Kevin S W Tan
Journal:  PLoS One       Date:  2016-08-10       Impact factor: 3.240

10.  Colonization with the enteric protozoa Blastocystis is associated with increased diversity of human gut bacterial microbiota.

Authors:  Christophe Audebert; Gaël Even; Amandine Cian; Alexandre Loywick; Sophie Merlin; Eric Viscogliosi; Magali Chabé
Journal:  Sci Rep       Date:  2016-05-05       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.